Literature DB >> 29311145

Depression and anxiety associate with less remission after 1 year in rheumatoid arthritis.

Aleid C Boer1, Tom W J Huizinga1, Annette H M van der Helm-van Mil1,2.   

Abstract

Entities:  

Keywords:  disease activity; early rheumatoid arthritis; psychology; rheumatoid arthritis

Mesh：

Substances：

Year:  2018        PMID： 29311145      PMCID： PMC6314454          DOI： 10.1136/annrheumdis-2017-212867

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  B Combe; R Landewe; C Lukas; H D Bolosiu; F Breedveld; M Dougados; P Emery; G Ferraccioli; J M W Hazes; L Klareskog; K Machold; E Martin-Mola; H Nielsen; A Silman; J Smolen; H Yazici
Journal:  Ann Rheum Dis       Date:  2006-01-05       Impact factor: 19.103

2.  Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study.

Authors:  Brigitte Michelsen; Eirik Klami Kristianslund; Joseph Sexton; Hilde Berner Hammer; Karen Minde Fagerli; Elisabeth Lie; Ada Wierød; Synøve Kalstad; Erik Rødevand; Frode Krøll; Glenn Haugeberg; Tore K Kvien
Journal:  Ann Rheum Dis       Date:  2017-07-21       Impact factor: 19.103

3.  Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms.

Authors:  S Ajeganova; H W van Steenbergen; J A B van Nies; L E Burgers; T W J Huizinga; A H M van der Helm-van Mil
Journal:  Ann Rheum Dis       Date:  2015-05-13       Impact factor: 19.103

4.  Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

Authors:  Y P M Goekoop-Ruiterman; J K de Vries-Bouwstra; C F Allaart; D van Zeben; P J S M Kerstens; J M W Hazes; A H Zwinderman; H K Ronday; K H Han; M L Westedt; A H Gerards; J H L M van Groenendael; W F Lems; M V van Krugten; F C Breedveld; B A C Dijkmans
Journal:  Arthritis Rheum       Date:  2005-11

5.  Predicting arthritis outcomes--what can be learned from the Leiden Early Arthritis Clinic?

Authors:  Diederik P C de Rooy; Michael P M van der Linden; Rachel Knevel; Tom W J Huizinga; Annette H M van der Helm-van Mil
Journal:  Rheumatology (Oxford)       Date:  2010-07-16       Impact factor: 7.580
  5 in total
  8 in total

1.  Systematic Review and Meta-analysis: Mindfulness-Based Interventions for Rheumatoid Arthritis.

Authors:  Dana DiRenzo; Monica Crespo-Bosque; Neda Gould; Patrick Finan; Julie Nanavati; Clifton O Bingham
Journal:  Curr Rheumatol Rep       Date:  2018-10-18       Impact factor: 4.592

Review 2.  Sarilumab: patient-reported outcomes in rheumatoid arthritis.

Authors:  Chiara Crotti; Martina Biggioggero; Andrea Becciolini; Ennio Giulio Favalli
Journal:  Patient Relat Outcome Meas       Date:  2018-08-20

3.  Depression and the risk of rheumatoid arthritis.

Authors:  Isabelle A Vallerand; Scott B Patten; Cheryl Barnabe
Journal:  Curr Opin Rheumatol       Date:  2019-05       Impact factor: 5.006

4.  Impact of arthritis on the perceived need and use of mental healthcare among Canadians with mental disorders: nationally representative cross-sectional study.

Authors:  Alyssa Howren; J Antonio Aviña-Zubieta; Deborah Da Costa; Joseph H Puyat; Hui Xie; Mary A De Vera
Journal:  BMJ Open       Date:  2020-12-10       Impact factor: 2.692

5.  Folate receptor-targeting mesoporous silica-coated gold nanorod nanoparticles for the synergistic photothermal therapy and chemotherapy of rheumatoid arthritis.

Authors:  Xiangyu Li; Yufei Hou; Xiangxue Meng; Ge Li; Fei Xu; Lesheng Teng; Fengying Sun; Youxin Li
Journal:  RSC Adv       Date:  2021-01-18       Impact factor: 3.361

6.  The association of depression and anxiety with treatment outcomes in patients with rheumatoid arthritis - a pooled analysis of five randomised controlled trials.

Authors:  Arkady T Manning-Bennett; Ashley M Hopkins; Michael J Sorich; Susanna M Proudman; David J R Foster; Ahmad Y Abuhelwa; Michael D Wiese
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-07-22       Impact factor: 3.625

7.  Anxiety impacts rheumatoid arthritis symptoms and health-related quality of life even at low levels.

Authors:  Dana D DiRenzo; Ethan T Craig; Clifton O Bingham Iii; Susan J Bartlett
Journal:  Clin Exp Rheumatol       Date:  2020-03-05       Impact factor: 4.473

8.  Posttraumatic Stress Disorder, Depression, Anxiety, and Persistence of Methotrexate and TNF Inhibitors in Patients with Rheumatoid Arthritis.

Authors:  Luke W Desilet; Bryant R England; Kaleb Michaud; Jennifer L Barton; Ted R Mikuls; Joshua F Baker
Journal:  ACR Open Rheumatol       Date:  2020-09-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.